Halley E. Gilbert
Independent DirectorDr. iur. Halley E. Gilbert, Esq. J.D., served as Chief Legal Officer and Chief Operating Officer at Tubulis GmbH (formerly known as Tubulis Technologies) from September 2025 to 2026. She served as Chief Legal Officer at CARGO Therapeutics, Inc. since joining it on August 2023. She was Chief Legal Officer of NeoGenomics Laboratories, Inc since October 2021 until 2022. She served as Chief Business Officer and Secretary of Adagio Therapeutics, Inc. and was Chief Operating Officer. She has been an Independent Director of Vaxcyte, Inc. since April 2020. Ms. Gilbert served as Chief Legal Officer and Corporate Secretary at NeoGenomics, Inc. since August 2021 until 2022. Ms. Gilbert served as Chief Operating Officer and Chief Business Officer at Adagio Therapeutics, Incorporated. She serves as Independent Director at CytomX Therapeutics, Inc. since April 27, 2020. She served as a Director of Dermira, Inc. from November 2019 to February 19, 2020. She served as Senior Vice President of Corporate Development and Chief Administrative Officer at Ironwood Pharmaceuticals, Inc. from March 2019 to February 28, 2020. Ms. Gilbert served as the Chief Legal Officer, Senior Vice President and Secretary at Ironwood Pharmaceuticals, Inc from 2014 to March 2019. Ms. Gilbert served as General Counsel of Ironwood Pharmaceuticals, Inc. since April 2008 and served as its Vice President of Legal Affairs. Ms. Gilbert served as Vice President of oversaw Pharmaceuticals, Inc. since April 2008. She served as Assistant Secretary of Ironwood Pharmaceuticals, Inc. She joined Ironwood Pharmaceuticals with corporate law. She served as President and Deputy General Counsel of Cubist Pharmaceuticals, Inc. At Cubist, she led legal efforts relating to securities, employment and benefits, clinical development, regulatory, sales and marketing and manufacturing. She served as Corporate Counsel of Genzyme Corporation and served as Associate of Skadden, Arps, Slate, Meagher & Flom, LLP. She served as Director of Allergy Amulet, Inc. until May 2022. She was a Director of Achaogen, Inc. since January 5, 2017 until April 4, 2019. Ms. Gilbert has been an Independent Director of Arcutis Biotherapeutics, Inc. since May 1, 2020. She was named Cubist Employee of the Year in 2006. In 2007, she was recognized by the Boston Business Journal as one of the top 40 under 40 business leaders in the Boston area. Ms. Gilbert received her JD from Northwestern University School of Law and a BA in Political Science from Tufts University.
Positions
- Company NameVaxcyte, Inc.Stock CodePCVXPositionIndependent DirectorColleagues
- GEGrant E. PickeringCo-Founder, CEO & Director
- CVCarlos V. PayaIndependent Chairman of the Board
- ALAndrew L. GuggenhimePresident & CFO
- JTJames T. WassilExecutive VP, Chief Scientific Officer & COO
- HSHarpreet S. DhaliwalChief Technical Operations Officer
- JFJeff FairmanCo-Founder & VP of Research
- HEHalley E. GilbertIndependent Director
- ASAnnie Seibold DrapeauIndependent Director
- TLTeri LoxamIndependent Director
- Company NameCytomX Therapeutics, Inc.Stock CodeCTMXPositionIndependent DirectorColleagues
- SASean A. McCarthyChairman & CEO
- CWChristopher W. OgdenSVP, CFO & Secretary
- RLRachael LesterChief Business Officer & Senior VP
- MPMarcia P. BelvinSenior VP & Chief Scientific Officer
- AVAlejandra Veronica CarvajalChief Legal Officer
- MPMatthew P. YoungLead Independent Director
- JRJames R. MeyersIndependent Director
- WMW. Michael KavanaughMember of Scientific Advisory Board
